WMU Biosciences Research & Commercialization Center — Full Portfolio

Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis.

HardwareHealthtechMedical DevicesNorthern California, US

RBRobert Ball(CEO & Executive Chairman)MAMatthew Ahearn(Chief Operating Officer)inJPJeff Points(Executive Officer)inDon Running(Manager and Chief Executive Officer)Jeff Ondrla(Chief Technology Officer)DLDavid L. Blue(Chief Customer Experience Officer)in

Co-investorsALAlumni VenturesAPAPERTURE Venture PartnersARArboretum VenturesGEGenesis Innovation GroupGLGlobal BrainINInvest Michigan+3 more

Advertent Biotherapeutics is a biotechnology company developing first-in-class biologics that modulate TGF-β family growth factors to protect muscle quality and promote regeneration in neuromuscular disorders, with a particular focus on muscular dystrophies.

BiotechDeep TechHealthtech

MFMonique Floer(Co-Founder, President & CEO)EMErik M. Martinez-Hackert(Co-Founder & CSO)

Co-investorsMIMichigan Rise

Developing an immune cell targeting platform to create first-in-class particle drug products for high unmet medical needs.

Co-investorsLOLoftyInc Capital

Coordinista provides technology solutions designed to improve engagement and care outcomes for high-acuity and hard-to-reach patient populations through clinician-friendly tools that support care teams in delivering meaningful care services.

Digital HealthHealthtechSaaS

Co-investorsMIMichigan Rise

Epsilon Imaging develops EchoInsight, a software platform that uses speckle-tracking strain imaging and automated analysis to detect cardiovascular dysfunction from echocardiograms earlier than traditional methods.

AI & Machine LearningDeep TechHealthtechMedical DevicesMichigan, US

EJEric J. Sieczka(Chairman, President and CEO)in

Co-investorsIDID Ventures

Espervita Therapeutics develops metabolic reprogramming therapies targeting liver and kidney disease, with a lead program in acetyl-CoA metabolic enzyme inhibitors.

BiotechDeep TechMedical Devices

Roger Newton(Founder / Board Advisor)James Lally(Founder / Board Advisor)

Co-investorsIDID VenturesMIMichigan Rise

Software that detects subtle vital-sign changes to warn medical professionals of post-operative patient deterioration risk.

JBJen Baird, NACD.DC(Founder)inMSMark Salamango(Founder)in

Co-investorsINInvest MichiganARArboretum VenturesCUCultivation Capital

Flightpath Biosciences develops microbiome-sparing, pathogen-specific drug candidates to treat infection-associated diseases by selectively targeting harmful bacteria while preserving healthy microbial communities.

BiotechDeep TechDigital HealthHealthtechMedical DevicesBirmingham, US

MTMatt Tindall(Founder)inMark P. de Souza(Executive Officer, Director)

BoardCurtis Scribner(Director)Cristina Larkin(Director)

Co-investorsFIFirst In VenturesIDID VenturesMIMichigan RiseACActive Capital

HealthtechGrand Rapids, US

Ryan Roeder(Executive Officer, Director)in

BoardMatt Ahearn(Director)Brian McCollum(Director)Ben Olds(Director)Matt Milanowski(Director)Steven Foster(Director)

Co-investorsGEGenesis Innovation Group

IASO Therapeutics develops synthetic antigen vaccines using a mutant Qβ virus-like particle carrier platform to generate targeted, durable immunity.

BiotechHealthtechEast Lansing, US

Robert Forgey(President & CEO)Xuefei Huang(Executive Officer, Director)Herbert Kavunja(Executive Officer)

BoardDonald Parfet(Director)JWJeffrey Wesley(Director)inSteve Kuemmerie(Director)

Co-investorsMIMichigan Rise

INHERET provides an online tool that collects detailed family health histories and evaluates hereditary cancer risk, then links to best-practice guidelines so providers can recommend next steps.

BiotechDigital HealthHealthtech

David Keren(Co-founder, MD)inKelly(CEO)Amanda

Native Traits recovers naturally occurring genetic traits from heritage crop varieties and incorporates them into hybrid seeds to improve yield, drought tolerance, and heat resilience.

AgTechBiotechKalamazoo, US

JFJames Friedrich(Executive Officer, Director)in

BoardSHSteve Haakenson(Director)inLee Huey(Director)Brian Steensma(Director)Larry Mayberry(Director)

Co-investorsINInvest Michigan

ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.

BiotechHealthtechMedical DevicesAnn Arbor, US

DZDavid Zacks(Co-Founder & Chief Scientific Officer)inDEDavid Esposito(Executive Officer, Director)inConstance Chang(Executive Officer)JKJohn K Freshley(Executive Officer, Director)inJAJeffrey A Jamison(Executive Officer)in

BoardAFAaron Fletcher(Director)in

Co-investorsEXExSight VenturesINInvest MichiganNONovartis Venture FundVIVisionary VenturesBIBios PartnersINInFocus Capital Partners, LLC+3 more

Peptinovo develops PALM™, a targeted drug-delivery platform that encapsulates chemotherapy drugs to deliver them directly to cancer cells while sparing healthy tissue, reducing side effects and enabling higher therapeutic doses.

BiotechDeep TechHealthtechMedical DevicesAnn Arbor, US

RHRen Homan(Founder)inREYNOLD HOMAN(Executive Officer, Director)BEBILL ELLIOTT(Executive Officer)inSTSTEVE TOKAZ(Executive Officer, Director)

BoardDAVID ROMENESCO(Director)FRED BROWN(Director)

Co-investorsIDID VenturesCACANTILEVER INVESTORS

Vestaron develops peptide-based insecticides derived from naturally-occurring peptides such as those found in spider venom, produced through fermentation, offering new modes of action for crop protection.

AgTechBiotechCleantechClimate TechNew MaterialsKalamazoo, US

GKGlenn King(Founder)inJEJuan Estupinan(Executive Officer, Director)inDDDawn de los Santos(Executive Officer)inRobert Kennedy(Executive Officer)Nancy Newman(Executive Officer)inJohn C. Sorenson(Executive Officer, Director)

Co-investorsARArgonautic VenturesCACavallo VenturesCUCultivian Sandbox VenturesENEndeavor8ISiSelect FundMIMichigan Capital Network+4 more